Criminal Justice | Behavioral Healthcare Executive Skip to content Skip to navigation

Criminal Justice

The least you need to know about Trump’s opioid plan

March 19, 2018  |  Julie Miller, Editor in Chief

On Monday, the White House rolled out its plan to address the opioid crisis, including a controversial call for harsher criminal justice policies as well as support for evidence-based treatment.

Trump proposal threatens future of ONDCP

January 19, 2018  |  Julie Miller, Editor in Chief

Previous attempts by the Trump administration to cut funding for ONDCP were met with resistance and ultimately were abandoned. If the current proposal moves forward, stakeholders are concerned that HIDTA and other initiatives would get lost.

DEA operation flags 26 potentially rogue pharmacies

December 6, 2017  |  Tom Valentino, Senior Editor

An operation conducted by the DEA’s Los Angeles field division has identified 26 pharmacies in southern California, Hawaii and Nevada that are suspected of violating the Controlled Substances Act.

Cost analysis backs immediate access to agonist drugs for opioid dependence

November 29, 2017  |  Gary A. Enos, Contributing Editor

A cost-effectiveness analysis using California data makes a strong case for significant public investment in methadone and buprenorphine treatment.

Urgent care centers for behavioral health outreach and care activation now emerging

November 19, 2017  |  Ron Manderscheid, PhD, Exec Dir, NACBHDD and NARMH

Incarceration of those with mental health, substance use, and, more recently, ID/DD conditions has grown dramatically during the past decade. Tonight, just a few days before Thanksgiving, our city and county jails will house about 731,000 persons.

States’ shortcomings drive reincarceration rates

September 20, 2017  |  Tom Valentino, Senior Editor

A study released by the Treatment Advocacy Center asserts that states’ inability to care for those with mental illness who have committed major crimes is driving up rearrest rates and draining public resources.

Missouri sets up PDMP at last—but with caveats

August 9, 2017  |  Julie Miller, Editor in Chief

Missouri is positioned to launch a statewide prescription drug monitoring program at last, but clinical professionals will not have access to patient-specific data to potentially prevent or treat addiction disorders.

New fraud unit targets pill mills

August 3, 2017  |  Julie Miller, Editor in Chief

The Department of Justice launched the Opioid Fraud and Abuse Detection Unit as a three-year pilot program, largely aimed at shutting down pill mills and drug diversion in 12 hard-hit states.

Race matters in psychiatry

July 25, 2017  |  H. Steven Moffic

Though we have improved in recent decades, Black Americans still are subject to being diagnosed erroneously, and still are underserved with certain treatment modalities like psychotherapy.

Largest takedown in history halts opioid diversion, brokering, kickbacks

July 14, 2017  |  Julie Miller, Editor in Chief

On Thursday, federal officials announced a massive enforcement action that involved charging 412 people, including some from addiction treatment centers.

Drug courts aim to broaden their scope

July 12, 2017  |  Julie Miller, Editor in Chief

There are about 3,000 drug courts in the United States, and as the number increases, experts say the models must become broader in scope as well as more nuanced in interactions with program participants.

Methadone proves its worth for incarcerated populations

June 28, 2017  |  Tom Valentino, Senior Editor

Incarcerated individuals who struggle with substance use disorder can benefit from methadone maintenance, mindfulness and other therapies, says Lipi Roy, MD, MPH, clinical assistant professor at the NYU Department of Population Health.


Subscribe to Criminal Justice